Literature DB >> 3127099

Subchondral pO2, pCO2, pressure, pH, and lactate in human osteoarthritis of the hip.

T Kiaer1, J Grønlund, K H Sørensen.   

Abstract

The pathogenesis of primary human osteoarthritis is unknown. It has been suggested that hypoxia caused by reduced subchondral blood flow plays a central role in the development of tissue damages in osteoarthritis. This hypothesis was investigated using an in situ technique based on mass spectrometry to measure subchondral pO2 and pCO2 in both femoral heads of patients with late stage unilateral osteoarthritis and the normal opposite hip. Intraosseous pressure was recorded and lactate concentrations and pH were measured in blood samples obtained from the two femoral heads. The subchondral pO2 in the diseased hip was significantly lower than pO2 in the normal hip (43 torr versus 63 torr). The intraosseous pressure was significantly higher in the diseased than in the normal hip. The lactate concentration showed a 50% increase in the diseased hip. There were no differences in pCO2 and pH between the two locations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127099

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  19 in total

Review 1.  Contribution of Circulatory Disturbances in Subchondral Bone to the Pathophysiology of Osteoarthritis.

Authors:  Roy K Aaron; Jennifer Racine; Jonathan P Dyke
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

2.  Pathophysiology and risk factors for osteonecrosis.

Authors:  Kalpit N Shah; Jennifer Racine; Lynne C Jones; Roy K Aaron
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

3.  Characterization of bone perfusion by dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography in the Dunkin-Hartley guinea pig model of advanced osteoarthritis.

Authors:  Jonathan P Dyke; Michael Synan; Paula Ezell; Douglas Ballon; Jennifer Racine; Roy K Aaron
Journal:  J Orthop Res       Date:  2014-11-19       Impact factor: 3.494

Review 4.  New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders.

Authors:  S C Ballara; J M Miotla; E M Paleolog
Journal:  Int J Exp Pathol       Date:  1999-10       Impact factor: 1.925

5.  Impact of medium volume and oxygen concentration in the incubator on pericellular oxygen concentration and differentiation of murine chondrogenic cell culture.

Authors:  Hiroki Oze; Makoto Hirao; Kosuke Ebina; Kenrin Shi; Yoshitaka Kawato; Shoichi Kaneshiro; Hideki Yoshikawa; Jun Hashimoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-01-19       Impact factor: 2.416

6.  Assessment of bone perfusion with contrast-enhanced magnetic resonance imaging.

Authors:  Jonathan H Lee; Jonathan P Dyke; Douglas Ballon; Deborah McK Ciombor; Glenn Tung; Roy K Aaron
Journal:  Orthop Clin North Am       Date:  2009-04       Impact factor: 2.472

Review 7.  Emerging role of metabolic signaling in synovial joint remodeling and osteoarthritis.

Authors:  Ronald K June; Ru Liu-Bryan; Fanxing Long; Timothy M Griffin
Journal:  J Orthop Res       Date:  2016-09-26       Impact factor: 3.494

8.  Subchondral fluid dynamics in a model of osteoarthritis: use of dynamic contrast-enhanced magnetic resonance imaging.

Authors:  J H Lee; J P Dyke; D Ballon; D M Ciombor; M P Rosenwasser; R K Aaron
Journal:  Osteoarthritis Cartilage       Date:  2009-04-17       Impact factor: 6.576

9.  Effects of low oxygen tension on gene profile of soluble growth factors in co-cultured adipose-derived stromal cells and chondrocytes.

Authors:  Sirong Shi; Jing Xie; Juan Zhong; Shiyu Lin; Tao Zhang; Ke Sun; Na Fu; Xiaoru Shao; Yunfeng Lin
Journal:  Cell Prolif       Date:  2016-04-19       Impact factor: 6.831

10.  Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes.

Authors:  Makoto Hirao; Jun Hashimoto; Naomi Yamasaki; Wataru Ando; Hideki Tsuboi; Akira Myoui; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2007-08-25       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.